维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Tiangco"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Diabetes nurse case management and motivational interviewing for change ( DYNAMIC ): Results of a 2‐year randomized controlled pragmatic trial (糖尿病护士病例管理以及促进改变的动机性会谈(DYNAMIC):一项为期2年的实用随机对照研究)显示文摘	Robert A. Gabbay Raquel M. A?el‐Tiangco Cheryl Dellasega David T. Mauger Alan Adelman Deborah H.A. Van Horn	2013	Journal of Diabetes2013，，：	3
2	Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients 显示文摘	Jordan J Tiangco B Kiss J	2000	Vox Sang2000，78，2：	1
3	Second-line bevacizumab- containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial 显示文摘	Brnfsky A Valero V Tiangco B	2012	Breast Cancer Res Treat2012，133，：	1
4	IGF-I and end-to-side nerve repair: a dose-response study显示文摘	Tiangco DA Papakonstantinou KC Mullinax KA	2001	J Reconstr Microsurg2001，17，4：	1
5	Effects of IGF-II in a new end-to-side model显示文摘	Caplan J Tiangco DA Terzis JK	1999	J Reconstr Microsurg1999，15，5：	1
6	3, 4- Methylenedioxymethamphetamine activates nuclear factor- kappaB, increases intracellular calcium, and modulates gene transcription in rat heart ceils 显示文摘	Tiangco D A Frank A L Osgood C J	2005	Cardiovasc Toxicol2005，5，3：	1
7	Second-line bev- acizumab-containing therapy in patients with triple-neg- ative breast cancer: subgroup analysis of the RIBBON- 2 trial显示文摘	Brufsky A Valero V Tiangco B	2012	Breast Cancer Res Treat2012，133，3：	1
8	Effects of IGF-Ⅱ in a new end-to-side model显示文摘	Caplan J Tiangco DA Terzis JK	1999	J Reconstr Microsurg1999，15，5：	1
9	Second-line bevacizumab- containing therapy in patients with triple-negative breast cancer:subgroup analysis of the RIBBON-2 trial显示文摘	Brufsky A Valero V Tiangco B	2012	Breast Cancer Res Treat2012，133，3：	1
10	Impact of bevacizumab ( BEV ) on efficacy of second- line chemotherapy(CT) for triple -nega tire breast cancer ( TNBC ) : analysis of RIBBON - 2 显示文摘	A Brufsky V Valero B Tiangco	2011	J Clin Oncol2011，，：	1
11	IGF-I and end-to-side nerve repair: a dose-response study 显示文摘	Tiangco DA Papakonstantinou KC Mullinax KA	2001	J Reconstr Microsurg2001，17，4：	1
12	IGF-Ⅰ and end-to-side nerve repair: a dose-response study显示文摘	Tiangco DA Papakonstantinou KC Mullinax KA	2001	J Reconstr Microsurg2001，17，4：	1
13	How patients with type 2 diabetes mellitus respond to motivational intervie- wing显示文摘	De\|lasega C Anel - Tiangco RM Gabbayb RA	2012	Diabetes Research and Clinical Practice2012，95，：	1
14	Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the R1BBON-2 trial 显示文摘	Brufsky A Valero V Tiangco B	2012	Breast Cancer Res Treat2012，133，3：	1
15	Secongd - line bev-acizumab -containing therapy in patients with triple -negative breast cancer: subgroup analysis of theRIBBON -2 trial显示文摘	Brufsky A Valero V Tiangco B	2012	Breast Cancer Res Treat2012，133，3：	1
16	Second-line bevacizumab- containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial显示文摘	Brufsky A Valero V Tiangco B	2012	Breast Cancer Res Treat2012，133，3：	1
17	IGF-I and end-to-side nerve repair:a dose-response study显示文摘	Tiangco DA Papakonstantinou KC Mul inax KA		0，，04：	1
18	IGF-Ⅰ and end-to-side nerve repair : a dose-response study 显示文摘	Tiangco DA Papakonstantinou KC Mullinax KA et al	2001	J Reconstr Microsurg2001，17，4：	1
19	: Gains and losses of the Ⅻ-Ⅶ component of the 'baby-sitter' procedure: a morphometric analysis显示文摘	Kalantarian B Rice DC Tiangco DA Terzis JK	1998	J Reconstr Microsurg1998，14，7：	1
20	Effects of IGF-Ⅱ in a new end-to-side model显示文摘	Caplan J Tiangco DA Terzis JK	1999	J Reconstr Microsurg1999，15，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示